Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dementia Alzheimer Type: early-phase trial registry
6 of 9 indexed Dementia Alzheimer Type trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 6 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Dementia Alzheimer Type: 9 US clinical trials tracked, 6 recruiting.
Dementia Alzheimer Type is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Cognito Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition dementia-alzheimer-type
OPEN 6 | RECR 67% | LATE 0 | EARLY 2 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Dementia Alzheimer Type lists 6 open slots (67% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dementia Alzheimer Type on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dementia Alzheimer Type is recruiting above its size-band peers.
6 of 9 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dementia Alzheimer Type trials is spread across many organizations.
Cognito Therapeutics accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Dementia Alzheimer Type trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.
-
Dementia Alzheimer Type research is mostly interventional.
7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
Pennington Biomedical Research Center
NCT03890861
Studies of Brain and Body Interaction
Rutgers University
NCT03672266
University of Central Florida Music Study
University of Central Florida
NCT07306065
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
University of California, Los Angeles
NCT06597942
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
MD Stem Cells
NCT06613971
Rifaximin SSD in Dementia Trial
Jasmohan Bajaj
NCT06718686
Multi-Center Study of Sensory Stimulation to Improve Brain Function
Cognito Therapeutics
NCT03556280
Partners at Meals - Respite Care and Home (PAM)
Medical University of South Carolina
NCT03622814
Movement Intervention for Memory Enhancement
Albert Einstein College of Medicine
NCT03475316
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Dementia Alzheimer Type records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dementia Alzheimer Type trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dementia Alzheimer Type page
9 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Dementia Alzheimer Type trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cognito Therapeutics sponsors the most Dementia Alzheimer Type trials on record, review their full trial history before evaluating a specific study. See Cognito Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia Alzheimer Type condition card totals 9 registered trials; most-linked intervention Enhanced Usual Condition; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.